Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

Tagged drug prices · clear

Patexia Insight 213: The Revlimid Dispute From Antitrust Battles to Patent Litigation

Revlimid (lenalidomide) , developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma since its FDA approval in 2005. The drug has also been at the center of complex legal…

July 25, 2024Pharma & ANDA3 min read

Unsorted

Winning the Drug Development Debate

The stage is being set for a coordinated attack on the patent system under the guise of making international health care more affordable. A newly released United Nations report encourages developing countries to use compulsory licenses to seize drugs,…

October 25, 2016Unsorted7 min read